The connected drug delivery devices market is projected to grow from USD 845.9 USD million in 2025 to USD 7,039.1 USD million by 2035, at a CAGR of 23.6%. Inhalation Devices will dominate with a 51.3% market share, while home care will lead the end user segment with a 44.7% share.